The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial)
Ghobain et al., Journal of Infection and Public Health, doi:10.1016/j.jiph.2022.11.016
https://c19early.org/ghobain.html